Sectors
DMAC
DiaMedica Therapeutics Inc.
6.35
2 x 4.56
2 x 8.03
bid
ask
-
0.04
0.63%
2 @ 04:10 PM
6.35 +0.00 (0.00%)
| Ytd | -20.23% | |
| 1y | 11.21% |
6.22
day range
6.59
5.14
52 week range
10.42
| Open | 6.44 | Prev Close | 6.39 | Low | 6.22 | High | 6.59 | Mkt Cap | 342.43M |
| Vol | 135.12K | Avg Vol | 193.30K | EPS | -0.72 | P/E | N/A | Forward P/E | -7.26 |
| Beta | 1.46 | Short Ratio | 3.88 | Inst. Own | 31.61% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 6.86 | 200-d Avg | 7.19 | 1yr Est | 7.00 |
| Income Statement | |||
| Operating Expenses | 10.13M | ||
| Research and Development Expense | 8.15M | ||
| Selling, General and Administrative Expense | 2.35M | ||
| Operating Income | -10.13M | ||
| Income Tax Expense | 7.00K | ||
| Net Income | -10.15M | ||
| Net Income Common Stock | -10.15M | ||
| Net Income Common Stock (USD) | -10.15M | ||
| Consolidated Income | -10.14M | ||
| Net Income to Non-Controlling Interests | 11.00K | ||
| Earnings per Basic Share | -0.19 | ||
| Earnings per Basic Share (USD) | -0.19 | ||
| Earnings per Diluted Share | -0.19 | ||
| Earning Before Interest & Taxes (EBIT) | -10.14M | ||
| Earning Before Interest & Taxes (USD) | -10.14M | ||
| Weighted Average Shares | 53.89M | ||
| Weighted Average Shares Diluted | 53.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.13M | ||
| Cash and Equivalents (USD) | 5.13M | ||
| Investments | 38.38M | ||
| Investments Current | 38.38M | ||
| Trade and Non-Trade Receivables | 244.00K | ||
| Current Assets | 44.32M | ||
| Property, Plant & Equipment Net | 286.00K | ||
| Total Assets | 45.00M | ||
| Debt Current | 116.00K | ||
| Total Debt | 185.00K | ||
| Current Liabilities | 6.59M | ||
| Debt Non-Current | 69.00K | ||
| Total Liabilities | 6.66M | ||
| Accumulated Retained Earnings (Deficit) | -192.95M | ||
| Accumulated Other Comprehensive Income | -37.00K | ||
| Shareholders Equity | 38.34M | ||
| Shareholders Equity (USD) | 38.34M | ||
| Assets Non-Current | 686.00K | ||
| Total Debt (USD) | 185.00K | ||
| Liabilities Non-Current | 69.00K | ||
| Trade and Non-Trade Payables | 2.81M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 34.00K | ||
| Net Cash Flow from Financing | 132.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 261.00K | ||
| Capital Expenditure | -3.00K | ||
| Issuance (Purchase) of Equity Shares | 135.00K | ||
| Issuance (Repayment) of Debt Securities | -3.00K | ||
| Net Cash Flow from Investing | 8.24M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 8.25M | ||
| Net Cash Flow from Operations | -8.11M | ||
| Share Based Compensation | 1.12M | ||